Human IDH mutant 1p/19q co-deleted gliomas have low tumor acidity as evidenced by molecular MRI and PET: a retrospective study
出版年份 2020 全文链接
标题
Human IDH mutant 1p/19q co-deleted gliomas have low tumor acidity as evidenced by molecular MRI and PET: a retrospective study
作者
关键词
-
出版物
Scientific Reports
Volume 10, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-07-17
DOI
10.1038/s41598-020-68733-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- 18F-DOPA uptake does not correlate with IDH mutation status and 1p/19q co-deletion in glioma
- (2019) Francesco Cicone et al. ANNALS OF NUCLEAR MEDICINE
- Cystathionine as a marker for 1p/19q codeleted gliomas by in vivo magnetic resonance spectroscopy
- (2019) Francesca Branzoli et al. NEURO-ONCOLOGY
- pH-weighted amine chemical exchange saturation transfer echoplanar imaging (CEST-EPI) as a potential early biomarker for bevacizumab failure in recurrent glioblastoma
- (2019) Jingwen Yao et al. JOURNAL OF NEURO-ONCOLOGY
- Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI
- (2019) Jingwen Yao et al. NEURO-ONCOLOGY
- Prognostic Roles of Central Carbon Metabolism–Associated Genes in Patients With Low-Grade Glioma
- (2019) Li Wang et al. Frontiers in Genetics
- Simultaneous pH-sensitive and oxygen-sensitive MRI of human gliomas at 3 T using multi-echo amine proton chemical exchange saturation transfer spin-and-gradient echo echo-planar imaging (CEST-SAGE-EPI)
- (2018) Robert J. Harris et al. MAGNETIC RESONANCE IN MEDICINE
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Simulation, phantom validation, and clinical evaluation of fast pH-weighted molecular imaging using amine chemical exchange saturation transfer echo planar imaging (CEST-EPI) in glioma at 3 T
- (2016) Robert J. Harris et al. NMR IN BIOMEDICINE
- Characterization of glucose-related metabolic pathways in differentiated rat oligodendrocyte lineage cells
- (2015) Ana I. Amaral et al. GLIA
- pH-weighted molecular imaging of gliomas using amine chemical exchange saturation transfer MRI
- (2015) Robert J. Harris et al. NEURO-ONCOLOGY
- IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma
- (2015) Philipp Kickingereder et al. Scientific Reports
- Mutations in CIC and IDH1 cooperatively regulate 2-hydroxyglutarate levels and cell clonogenicity
- (2015) Suganthi Chittaranjan et al. Oncotarget
- Extracellular acidity, a “reappreciated” trait of tumor environment driving malignancy: perspectives in diagnosis and therapy
- (2014) Silvia Peppicelli et al. CANCER AND METASTASIS REVIEWS
- Neural stem/progenitor cells display a low requirement for oxidative metabolism independent of hypoxia inducible factor-1alpha expression
- (2013) Kate M. Candelario et al. JOURNAL OF NEUROCHEMISTRY
- Lactate dehydrogenase A silencing in IDH mutant gliomas
- (2013) Charles Chesnelong et al. NEURO-ONCOLOGY
- Recurrent Glioblastoma Treated with Bevacizumab: Contrast-enhanced T1-weighted Subtraction Maps Improve Tumor Delineation and Aid Prediction of Survival in a Multicenter Clinical Trial
- (2013) Benjamin M. Ellingson et al. RADIOLOGY
- 11C-Methionine Uptake Correlates with Combined 1p and 19q Loss of Heterozygosity in Oligodendroglial Tumors
- (2012) T. Saito et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- DNA hypermethylation and 1p Loss silence NHE-1 in oligodendroglioma
- (2012) Michael D. Blough et al. ANNALS OF NEUROLOGY
- The role of LAT1 in 18F-DOPA uptake in malignant gliomas
- (2012) Ryan S. Youland et al. JOURNAL OF NEURO-ONCOLOGY
- Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
- (2012) Peppi Koivunen et al. NATURE
- Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [18F]FET-PET imaging in intracranial WHO grade II and III gliomas
- (2012) N. L. Jansen et al. NEURO-ONCOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Evidence for Sequenced Molecular Evolution of IDH1 Mutant Glioblastoma From a Distinct Cell of Origin
- (2011) Albert Lai et al. JOURNAL OF CLINICAL ONCOLOGY
- Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers
- (2011) Stephen Yip et al. JOURNAL OF PATHOLOGY
- Combined spin- and gradient-echo perfusion-weighted imaging
- (2011) Heiko Schmiedeskamp et al. MAGNETIC RESONANCE IN MEDICINE
- Non-Stem Cell Origin for Oligodendroglioma
- (2010) Anders I. Persson et al. CANCER CELL
- Relationship between radiological characteristics and combined 1p and 19q deletion in World Health Organization grade III oligodendroglial tumours
- (2010) J. W. Kim et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2
- (2010) M. Labussiere et al. NEUROLOGY
- Magnetic resonance perfusion-weighted imaging defines angiogenic subtypes of oligodendroglioma according to 1p19q and EGFR status
- (2009) Gurpreet S. Kapoor et al. JOURNAL OF NEURO-ONCOLOGY
- Tumor Cell Metabolism: Cancer's Achilles' Heel
- (2008) Guido Kroemer et al. CANCER CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now